Givaudan announced an agreement with food ingredients company, COMET, to become an authorized distributor of its natural, gut-friendly fibre Arrabina1 for the US market.

Arrabina is a gluten-free wheat fibre extract2, with a naturally diverse and unique composition. Unlike other isolated fibres, Arrabina is a unique mix of prebiotics as found in nature, including arabinoxylan and lignin, and is bundant in polyphenols. This dietary fibre is shown to have a microbiome-modulating effect3 and exceptional tolerability, even at three servings daily4.

Consumers are increasingly becoming aware of the role of the gut in their wellbeing. 72% of consumers say that digestive health is an important aspect of their overall health5. But 90% – or 300 million Americans – fall short of the fibre consumption needed6, leading to increased demand for innovative nutraceutical and food and beverage products.

“We are delighted to collaborate with COMET and offer its unique, natural fibre that is sustainably sourced. We selected COMET’s Arrabina as it allows our customers to enhance the nutritional value of their products and deliver innovative food experiences with gut health benefits,” says Timothee Olagne, Health and Nutrition Category Director, Givaudan.

“As we enter into our second year of full-scale production, we are excited to collaborate with Givaudan to expand our market reach for Arrabina,” says Loula Merkel, chief executive officer of COMET

Arrabina is stable, making it a suitable ingredient for a variety of applications. This sustainable fibre is upcycled certified, has a low carbon footprint and also uses renewable energy for production. The new ingredient complements Givaudan’s oat prebiotic fibre, OatWell, providing a portfolio of fibre ingredients to address the growing consumer demand for gut health solutions.

• Arrabina is an upcycled wheat fiber extract containing a mix of arabinoxylan, oligosaccharides and medium chain polysaccharides

• Gluten-free wheat fiber extract refers to wheat that has been processed to allow this food to meet the Food and Drug Administration (FDA) requirements for gluten-free foods.

• Ex vivo model of intestinal fermentation, Cryptobiotix study, data on file (2024)

• Chen O et al., The Effect of Arabinoxylan on Gastrointestinal Tolerance in Generally Healthy Adults: A Randomized, Placebo-Controlled, Crossover Study. Curr Dev Nutr. 2021 Jun 7;5(Suppl 2):304.

• IFIC consumer study

• Miketinas, D., Tucker, W. J., Douglas, C. C., & Patterson, M. (2023). Usual dietary fibre intake according to diabetes status in USA adults – NHANES 2013–2018. British Journal of Nutrition, 1–9.